Opioids in preclinical and clinical trials

Topics in Current Chemistry

Volumn 299, Issue , 2011, Pages 29-62

  Nagase, Hiroshi ^a   Fujii, Hideaki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Clinical development; Nonnarcotic; Opioid drug; TRK 820; TRK 851

Indexed keywords

17 CYCLOPROPYLMETHYL 6,7 DIDEHYDRO 4,5 EPOXY 8' FLUORO 5',6' DIHYDRO 4'H PYRROLO(3,2,1 IJ)QUINOLINO(2',1' 6,7)MORPHINAN 3,14 DIOL; 17-CYCLOPROPYLMETHYL-6,7-DIDEHYDRO-4,5-EPOXY-8'-FLUORO-5',6'-DIHYDRO-4'H-PYRROLO(3,2,1-IJ)QUINOLINO(2',1'-6,7)MORPHINAN-3,14-DIOL; ANTITUSSIVE AGENT; DELTA OPIATE RECEPTOR; DRUG DERIVATIVE; KAPPA OPIATE RECEPTOR; MORPHINAN DERIVATIVE; NALFURAFINE; NALTREXONE; SPIRO COMPOUND;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; DRUG DEVELOPMENT; DRUG POTENTIATION; HUMAN; MOLECULAR GENETICS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTITUSSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DRUG DISCOVERY; HUMANS; MOLECULAR SEQUENCE DATA; MORPHINANS; NALTREXONE; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; SPIRO COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79551477325     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128_2010_74     Document Type: Article

References (68)

1. Gates M, Tschudi G (1952) J Am Chem Soc 74:1109
2. Casy AF, Parfitt RT (1986) Opioid analgesics, chemistry and receptors. Plenum, New York
3. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) J Pharmacol Exp Ther 197:517
4. Takemori AE, Larson DL, Portoghese PS (1981) Eur J Pharmacol 70:445
5. DeLander GE, Portoghese PS, Takemori AE (1984) J Pharmacol Exp Ther 231:91
6. Sakami S, Kawai K, Maeda M, Aoki T, Fujii H, Ohno H, Ito T, Saitoh A, Nakao K, Izumimoto N, Matsuura H, Endo T, Ueno S, Natsume K, Nagase H (2008) Bioorg Med Chem 16:7956
7. Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, Tajima C, Endo T (1988) Chem Pharm Bull 46:366
8. Turgeon J, Gröning R, Sathyan G, Thipphawong J, Richarz U (2010) Expert Opin Drug Deliv 7:137
9. Matsumoto AK (2007) Expert Opin Pharmacother 8:1515
10. Nelson L, Schwaner R (2009) J Med Toxicol 5:230
11. Vadivelu N, Hines RL (2008) Clin Interv Aging 3:421
12. Stauffer J, Setnik B, Sokolowska M, Romach M, Johnson F, Sellers E (2009) Clin Drug Investig 29:777
13. Diego L, Atayee R, Helmons P, von Gunten CF (2009) Expert Rev Gastroenterol Hepatol 3:473
14. Bream-Rouwenhorst HR, Cantrell MA (2009) Am J Health Syst Pharm 66:1267
15. Calderon SN, Coop A (2004) Curr Pharm Des 10:733
16. Gengo PJ, Pettit HO, O'Neill SJ, Wei K, McNutt R, Bishop MJ, Chang KJ (2003) J Pharmacol Exp Ther 307:1221
17. Le Bourdonnec B, Windh RT, Ajello CW, Leister LK, Gu M, Chu GH, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Christ DD, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE (2008) J Med Chem 51:5893
18. Le Bourdonnec B, Windh RT, Leister LK, Zhou QJ, Ajello CW, Gu M, Chu GH, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE (2009) J Med Chem 52:5685
19. Katsura Y, Zhang X, Homma K, Rice KC, Calderon SN, Rothman RB, Yamamura HI, Davis P, Flippen-Anderson JL, Xu H, Becketts K, Foltz EJ, Porreca F (1997) J Med Chem 40:2936
20. Nagase H,Kawai K,Hayakawa J,WakitaH, MizusunaA,Matsuura H,TajimaC,Takezawa Y, Endoh T (1998) Chem Pharm Bull 46:1695
21. Nagase H, Yajima Y, Fujii H, Kawamura K, Narita M, Kamei J, Suzuki T (2001) Life Sci 68:2227
22. Portoghese PS, Takemori AE (1994) USP 5,352,680
23. Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H (1995) Life Sci 57:PL247
24. Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H (1997) Pharmacol Biochem Behav 57:293
25. Arakawa K, Akami T, Okamoto M, Akioka K, Nakai I, Oka T, Nagase H (1993) Transplant Proc 25(1 Pt 1):738
26. Gavériaux-Ruff C, Filliol D, Simonin F, Matthes HW, Kieffer BL (2001) J Pharmacol Exp Ther 298:1193
27. Piercey MF, Lahti RA, Schroeder LA, Einspahr FJ, Barsuhn C (1982) Life Sci 31:1197
28. Kawai K, Hayakawa J, Miyamoto T, Imamura Y, Yamane S, Wakita H, Fujii H, Kawamura K, Matsuura H, Izumimoto N, Kobayashi R, Endo T, Nagase H (2008) Bioorg Med Chem 16:9188
29. Costello GF, Main BG, Barlow JJ, Carroll JA, Shaw JS (1988) Eur J Pharmacol 151:475
30. Halfpenny PR, Horwell DC, Hughes J, Hunter JC, Rees DC (1990) J Med Chem 33:286
31. Chang KF, Chang AB (2002) Pulm Pharmacol Ther 15:335
32. Bolser DC (2006) Respir Physiol Neurobiol 152:349
33. Kamei J, Tanihara H, Kasuya Y (1990) Eur J Pharmacol 187:281
34. Kamei J, Tanihara H, Kasuya Y (1991) Eur J Pharmacol 203:153
35. Kamei J, Tanihara H, Kasuya Y (1992) Chem Pathol Pharmacol 76:375
36. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y (1993) Eur J Pharmacol 249:161
37. Hitchcock SA, Pennington LD (2006) J Med Chem 49:7559
38. Kerns E, Di L (2008) Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization. Academic, London
39. Sakami S, Maeda M, Kawai K, Aoki T, Kawamura K, Fujii H, Hasebe K, Nakajima M, Endo T, Ueno S, Ito T, Kamei J, Nagase H (2008) J Med Chem 51:4404
40. Nagase H, Kawai K, Kawamura K, Hayakawa J, Endo T (1993) WO 93/15081
41. Portoghese PS, Lipkowski AW, Takemori AE (1987) J Med Chem 30:238
42. Portoghese PS, Sultana M, Nagase H, Takemori AE (1988) J Med Chem 31:281
43. Nogrady T (1985) Medicinal chemistry, a biochemical approach. Oxford University Press, New York
44. Portoghese PS, Nagase H, Takemori AE (1988) J Med Chem 31:1344
45. Lin CE, Takemori AE, Portoghese PS (1993) J Med Chem 36:2412
46. Shook JE, Pelton JT, Wire WS, Hirning LD, Hruby VJ, Burks TF (1987) J Pharmacol Exp Ther 240:772
47. Endo T, Matsuura H, Tajima A, Izumimoto N, Tajima C, Suzuki T, Saitoh A, Suzuki T, Narita M, Tseng L, Nagase H (1999) Life Sci 65:1685
48. Kanematsu K (1998) Yakugaku Zasshi 118:1
49. Katsumata S, Ienaga Y, Minami M, Nakagawa T, Kanematsu K, Satoh M (1996) Eur J Pharmacol 312:349
50. Hosoki R, Niizawa S, Koike K, Sagara T, Kanematsu K, Takayanagi I (1996) Arch Int Pharmacodyn Ther 331:136
51. Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H (2002) Eur J Pharmacol 435:259
52. Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H (2003) Eur J Pharmacol 477:29
53. Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, Nagase H (2004) Life Sci 75:2947
54. Utsumi J, Togashi Y, Umeuchi H, Okano K, Tanaka T, Nagase H (2004) In: Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F (ed)s) Itch. Basic mechanisms and therapy. Marcel Dekker, New York, p 107
55. Inan S, Cowan A (2004) Eur J Pharmacol 502:233
56. Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DYW, Huang P, Li J-G, Cowan A, Liu-Chen L-Y (2005) J Pharmacol Exp Ther 312:220
57. Nakao K, Mochizuki H (2009) Drugs Today 45:323
58. Ko MC, Husbands SM (2009) J Pharmacol Exp Ther 328:193
59. Cousins MJ, Mather LE (1984) Anesthesiology 61:276
60. Ballantyne JC, Loach AB, Carr DB (1988) Pain 33:149
61. Kuraishi Y, Nagasawa T, Hayashi K, Satoh M (1995) Eur J Pharmacol 275:229
62. Andoh T, Nagasawa T, Satoh M, Kuraishi Y (1998) J Pharmacol Exp Ther 286:1140
63. Tohda C, Yamaguchi T, Kuraishi Y (1997) Jpn J Pharmacol 74:77
64. Umeuchi H, Kawashima Y, Aoki CA, Kurokawa T, Nakao K, Itoh M, Kikuchi K, Kato T, Okano K, Gershwin ME, Miyakawa H (2005) Eur J Pharmacol 518:133
65. Inan S, Cowan A (2006) Pharmacol Biochem Behav 85:39
66. WikströmB, Gellert R, Ladefoged SD, Danda Y,Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y (2005) J Am Soc Nephrol 16:3742
67. Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H (2009) Nephrol Dial Transplant (in press). doi:10.1093/ndt/gfp588
68. Kumagai H, Ebata T, Suzuki H, Takamori K (2008) 10th Souyaku vision symposium, Tokyo, 18-19 Dec 2008, The Pharmaceutical Society of Japan, p 24